CLOVIS ONCOLOGY INC - NOTE 1.250% 5/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2018 to Q1 2023

Type / Class
Debt / NOTE 1.250% 5/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 1.250% 5/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2023 Q1 $0 $0 -$4,723,000 0
2022 Q4 $23,616,000 $4,723,000 -$207,893,148 20.0% 1
2022 Q3 $293,760,000 $203,520,174 -$19,026 69.98% 15
2022 Q2 $293,760,000 $205,715,292 +$20,902,020 70.21% 15
2022 Q1 $263,760,000 $197,018,429 -$20,024,997 75.0% 15
2021 Q4 $293,260,000 $203,367,621 +$87,634 69.51% 16
2021 Q3 $294,525,000 $212,008,321 -$1,830,538 72.25% 18
2021 Q2 $295,310,000 $219,009,973 +$3,579,103 74.19% 21
2021 Q1 $290,446,000 $220,409,278 -$16,143,777 75.76% 19
2020 Q4 $256,757,000 $179,703,388 -$2,495,236 70.14% 20
2020 Q3 $293,785,000 $203,302,654 +$2,085,587 69.99% 21
2020 Q2 $291,660,000 $176,183,480 +$3,455,361 60.56% 23
2020 Q1 $286,660,000 $177,678,635 -$2,097,442 61.39% 23
2019 Q4 $290,420,000 $183,963,067 +$10,635,614 63.64% 25
2019 Q3 $291,389,000 $125,362,537 +$3,201,412 42.12% 30
2019 Q2 $280,395,000 $175,456,282 +$13,763,472 62.31% 29
2019 Q1 $250,219,500 $195,997,000 -$10,028,159 78.0% 32
2018 Q4 $274,047,500 $193,351,000 -$25,528,876 70.27% 31
2018 Q3 $291,933,000 $227,461,000 +$3,558,931 77.6% 30
2018 Q2 $284,941,459 $264,395,459 +$264,395,684 92.1% 33